Jennifer J. Rhodes
EVP, CHIEF LEGAL OFFICER, SEC · ACADIA PHARMACEUTICALS INC
- 2026
- Mar 27, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer J. Rhodes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
- Adams Catherine Owen - $250K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer J. Rhodes?
Jennifer J. Rhodes is a corporate insider, tracked as EVP, CHIEF LEGAL OFFICER, SEC of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jennifer J. Rhodes last file a Form 4?
The most recent primary Form 4 on record is dated 27 March 2026, one of 3 filings going back to 2026.
Has Jennifer J. Rhodes been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($245K) across all tracked filings.
